Regenerative Protein 1 Year Protocol
Groundbreaking advancement in the field of regenerative medicine. (Protein Arrays) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue. More regenerative proteins than all Stem Cell, Exosome, Bone Marrow, Wharton’s Jelly, Amniotic Fluid, Cord Blood combined. Over (100X) more powerful than PRP treatment.
This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages. ₁
Regulatory Profile
Protein arrays contain no live cells, only proteins, the FDA classifies protein arrays in a unique category which and has no governance over such proteins at this time.
Groundbreaking advancement in the field of regenerative medicine. (Protein Arrays) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue. More regenerative proteins than all Stem Cell, Exosome, Bone Marrow, Wharton’s Jelly, Amniotic Fluid, Cord Blood combined. Over (100X) more powerful than PRP treatment.
This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages. ₁
Regulatory Profile
Protein arrays contain no live cells, only proteins, the FDA classifies protein arrays in a unique category which and has no governance over such proteins at this time.
Groundbreaking advancement in the field of regenerative medicine. (Protein Arrays) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue. More regenerative proteins than all Stem Cell, Exosome, Bone Marrow, Wharton’s Jelly, Amniotic Fluid, Cord Blood combined. Over (100X) more powerful than PRP treatment.
This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages. ₁
Regulatory Profile
Protein arrays contain no live cells, only proteins, the FDA classifies protein arrays in a unique category which and has no governance over such proteins at this time.